Upadacitinib is efficacious as induction and maintenance therapy for refractory pediatric ulcerative colitis and IBD-U.
DGBIs are common among children with obesity and are significantly associated with altered bile acid levels and metabolic comorbidities.
The HHS found that nursing homes inappropriately diagnosed schizophrenia to hide giving antipsychotic drugs to residents with dementia.